2004, Número 3
<< Anterior Siguiente >>
Rev Biomed 2004; 15 (3)
Lupus eritematoso: enfermedad autoinmune sistémica y órgano específica
Sánchez-Rodríguez SH, Barajas-Vásquez GE, Ramírez-Alvarado ED, Moreno-García A, Barbosa-Cisneros OY
Idioma: Español
Referencias bibliográficas: 38
Paginas: 173-180
Archivo PDF: 92.15 Kb.
RESUMEN
En los pacientes que desarrollan lupus, su sistema inmune se activa y se vuelve contra el mismo huésped, por lo que es considerada una enfermedad autoinmune. En los Estados Unidos, existe más de un millón de personas que presenta Lupus. Sus síntomas aparecen en una gran variedad de formas, en los cuales la mitad de los casos es letal. El daño aparece en cualquier órgano del cuerpo y puede causar artritis con inflamación, fatiga, eritema en alas de mariposa en región malar, úlceras orales, fotosensibilidad, serositis (inflamación del tejido alrededor del corazón y pulmón), osteoporosis, desórdenes renales (proteinuria y destrucción celular), desórdenes sanguíneos (leucopenia, linfopenia, trombocitopenia, anemia hemolítica), desórdenes inmunológicos (anticuerpos anti-DNA y anti-Sm) y títulos de anticuerpos antinucleares anormales.
Utilizando técnicas de biología molecular, se han descubierto algunos factores que regulan el sistema inmune, así como mecanismos bioquímicos por los cuales en el lupus se presenta daño al tejido. También se han identificado algunos genes candidato que parecen estar involucrados en el lupus.
REFERENCIAS (EN ESTE ARTÍCULO)
Marshall Eliot. Lupus: Mysterious disease holds Its secrets tight. Science 2002; 296:689.
Mason LJ, Evans JG, Putterman C, Isenberg DA. AntidsDNA antibodies purified from patients with lupus nephritis bind to alpha-actinin. http://www.abstractonline.com/viewer/searchAdvancedResults.asp
Flaus A, Tom Owen-Hughes T. Mechanisms for nucleosome movilization. Biopolymers. 2003; 68:563-78.
Bruns A, Bläss S, Hausdorf G, Burmester GR, Hiepe F. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis & Rheumatism. 2000; 43:2307-15.
Grootscholten C, van Bruggen MCJ, van der Pijl JW, de Jong EMGJ, Ligtenberg G, Derksen RHWM, et al. Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis. Arthritis & Rheumatism. 2003; 48:1355-62.
Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, et al. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: Antinucleosome antibodies of the IgG3 subclass are makers of renal pathogenicity in systemic lupus erythematosus. Arthritis & Rheumatism. 2000; 43:76-84.
Schett G, Rubin RL, Steiner G, Hiesberger H, Muller S, Smolen J. The lupus erythematosus cell phenomenon: Comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera. Arthritis & Rheumatism. 2000; 43:420-8.
Kita Y, Kuroda K, Mimori T, Hashimoto T, Yamamoto K, Saito Y, et al. T cell receptor clonotypes in skin lesions from patients with systemic lupus eryhematosus. J Invest Dermatol 1998; 110:41-6.
Chan LS, Vanderlugt CJ, Hashimoto T, Nishikawa T, Zone JJ, Black MM, et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol 1998; 110:103-9.
Villalobos-Hurtado R, Avalos-Díaz E, Herrera-Esparza R. Inmunorreactantes glomerulares en nefropatía lúpica. Boletín CIAR 1996; 6:3-6.
Bollain-y Goytia JJ. (Tesis). La luz ultravioleta A aumenta la transcripción de los genes fas-L y bax y contribuye a la redistribución de la proteína Ro60 de queratinocitos. Unidad Académica de Biología Experimental: Universidad Autónoma de Zacatecas; 2001.
Provost TT, Watson R. Anti-Ro(SS-A) HLA-DR3- positive women: the interrelationship between some ANA negative, SS,SCLE, and NLE mothers and SS/LE overlap female patients. J Invest Dermatol 1993; 100:14-20.
Norris DA. Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol 1993; 100:58-68.
Discoid lupus erythematosus. www.dermnetnz.org/dna.discoid/info.html
LUPUS. If you (or one of your loved ones) have Lupus, you will remember this day for the rest of your life. Why? www.thehomeostasisprotocol.com
Discoid lupus erythematosus. www.skinsite.com/info_discoid_lupus_erythematosus.htm
Discoid lupus erythematosus. tray.dermatology.uiowa.edu/DLE-003.htm
Werth VP, Duts JP, Sontheimer RD. Pathogenetic mechanism and treatment of cutaneous lupus erythematosus. Curr Op Rheumatology 1997; 9:400-9.
Callen JP. Neonatal lupus and cutaneous lupus erythematosus in children. Copyright 2003, eMedicine.com, Inc.
Buyon JP. Autoantibodies reactive with Ro(SS-A) and La (SS-B) and pregnacy. J Rheumatol 1997; 24:12-16.
Lupus cutané subaigu. Article publié dans la revue Actualité Médicale. Du 29 janvier 1997; 18(4). www.callisto.si.usherb.ca/~94268233/medecine.htm
Hruza LL, Pentland AP. Mechanisms of UV-induced inflammation. J Invest Dermatol 1993; 100:35-41.
Berton TR, Mitchell DL, Fischer SM, Locniskar MF. Epidermal proliferation but not the quantity of DNA photodamage is correlated with UV-induced mouse skin carcinogenesis. J Invest Dermatolol 1997; 109:340-7.
Avalos-Díaz E, Alvarado-Flores E, Herrera-Esparza R. UVA irradiation stimulates the synthesis of inflammatory cytokines in human dermal fibroblasts. Rev Rhum 1999,66:13-9.
Rosette C, Karin M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science 1996; 274:1194-7.
Konodo S, Sauder DN, Kono T, Galley KM, McKenzie RC. Differential modulation of interleukin-1a (IL-1a) and interleukin-1b (IL-1b) in human epidermal keratinocytes by UVB. Exp Dermatol 1994; 3:29-39.
Kemény L, Michel G, Ruzicka T. Cytokine system as potential target for antipsoriatic therapy. Exp Dermatol 1994; 3:1-8.
Trefzer U, Brockhaus M, Lötscher H, Parlow F, Budnik A, Grewe M, et al. The 55-KD tumor necrosis receptors on human keratinocytes is regulated by tumor necrosis factoralpha and by ultraviolet B radiation. J Clin Invest 1993; 92:462-70.
Kind P, Lehmann P, Plewig G. Phototesting in lupus erythematosus. J Invest Dermatol 1993; 100:53-7.
Cassiola-Rosen LA, Anhalt GJ, Rosen A. Autoantigen targeted in systemic lupus eryhematosus are clustered in two populations of surface blebs on cultured keratinocytes. J Exp Med 1994; 179:1317-30.
Avalos-Díaz E, Aguilera-Galaviz A, Herrera-Esparza R. UV-A Irradiation increases the expression of the 60 kD Ro antigen in human keratinocytes. Chron Derm 1996; 6:791-801.
Bollain-y-Goytia JJ, Avalos-Díaz E, Herrera-Esparza R. Fas ligand and Bax gene trascription contributes to Ro60 ribonucleoprotein redistribution in UV-A irradiated human keratinocytes. Joint Bone Spine. 2000; 67:283-9.
Zheng ZS, Chen RZ, Prystowsky JH. UVB radiation induces hosphorylation of the epidermal growth factor receptor, decreases EGF binding, and blocks EGF induction of ornithine decarboxylase gene expression in SV40- transformed human keratinocytes. Exp Dermatol 1993; 2:257-65.
Wantanabe R, Otsuka F. Cultured skin fibroblasts derived from three patients disseminated superficial actinic porokeratosis (DSAP) are hypersensitive to the lethal effects of X-radiation but not to those of ultraviolet (UV) light. Exp Dermatol 1993; 2:175-8.
Tanew A, Ortel B, Hönigsmann H. UVA does not photoreactivate pyrimidine dimers in cultured human fibroblasts. Exp Dermatol 1993; 2:161-4.
Benassi L, Ottani D, Fantini F, Marconi A, Chiodino C, Giannetti A, et al. 1,25-Dihydroxyvitamin D3, transforming growth factor B1, calcium, ultraviolet B irradiaton induce apoptosis in cultured human keratinocytes. J Invest Dermatol 1997; 109:276-82.
Herrlich P, Rahmsdorf HJ. Transcriptional and posttranscriptional responses to DNA-damaging agents. Curr Op Cell Biol 1994; 6:425-31.
Pahl HL, Baeuerle PA. Control of gene expression by proteolysis. Curr Op Cell Biol 1996; 8:340-7.